Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 6 | 2025 | 617 | 2.720 |
Why?
|
| Spices | 2 | 2022 | 5 | 1.430 |
Why?
|
| Cardiovascular Diseases | 3 | 2025 | 2111 | 1.070 |
Why?
|
| Vascular Stiffness | 3 | 2023 | 494 | 0.810 |
Why?
|
| Postprandial Period | 2 | 2022 | 107 | 0.810 |
Why?
|
| Cardiovascular System | 1 | 2023 | 137 | 0.740 |
Why?
|
| Dietary Carbohydrates | 1 | 2020 | 155 | 0.620 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 558 | 0.610 |
Why?
|
| Dietary Fats | 1 | 2020 | 304 | 0.580 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 496 | 0.570 |
Why?
|
| Cytokines | 2 | 2023 | 2085 | 0.540 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 1046 | 0.440 |
Why?
|
| Diet | 1 | 2022 | 1278 | 0.420 |
Why?
|
| Monocytes | 2 | 2023 | 563 | 0.320 |
Why?
|
| Cross-Over Studies | 2 | 2022 | 564 | 0.300 |
Why?
|
| Hypercapnia | 2 | 2023 | 53 | 0.250 |
Why?
|
| Anti-Obesity Agents | 3 | 2015 | 57 | 0.250 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2024 | 128 | 0.210 |
Why?
|
| Phytotherapy | 2 | 2014 | 83 | 0.200 |
Why?
|
| Nutrition Surveys | 1 | 2023 | 266 | 0.180 |
Why?
|
| Global Health | 1 | 2025 | 386 | 0.180 |
Why?
|
| Plant Extracts | 2 | 2014 | 202 | 0.180 |
Why?
|
| Pulse Wave Analysis | 1 | 2023 | 272 | 0.180 |
Why?
|
| Postmenopause | 1 | 2023 | 366 | 0.180 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2022 | 140 | 0.180 |
Why?
|
| Blood Pressure | 3 | 2023 | 1786 | 0.180 |
Why?
|
| Leukocyte Count | 1 | 2022 | 329 | 0.180 |
Why?
|
| Risk Factors | 3 | 2025 | 10388 | 0.170 |
Why?
|
| Cerebrovascular Circulation | 1 | 2023 | 243 | 0.170 |
Why?
|
| Meals | 1 | 2022 | 125 | 0.170 |
Why?
|
| Humans | 12 | 2025 | 137585 | 0.160 |
Why?
|
| Fasting | 1 | 2022 | 281 | 0.160 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 622 | 0.160 |
Why?
|
| Aged | 4 | 2023 | 23961 | 0.160 |
Why?
|
| Male | 7 | 2025 | 67762 | 0.160 |
Why?
|
| Lymphocytes | 1 | 2022 | 397 | 0.160 |
Why?
|
| Cell Culture Techniques | 1 | 2022 | 363 | 0.160 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2023 | 262 | 0.160 |
Why?
|
| Dementia | 1 | 2023 | 259 | 0.160 |
Why?
|
| Cognition | 2 | 2024 | 1153 | 0.150 |
Why?
|
| Sex Factors | 1 | 2025 | 2071 | 0.150 |
Why?
|
| Testosterone | 1 | 2022 | 409 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2023 | 762 | 0.140 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 354 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2023 | 785 | 0.130 |
Why?
|
| Diet, High-Fat | 2 | 2015 | 247 | 0.130 |
Why?
|
| Female | 5 | 2025 | 73304 | 0.130 |
Why?
|
| Rutin | 1 | 2015 | 3 | 0.120 |
Why?
|
| Organelle Biogenesis | 1 | 2015 | 15 | 0.120 |
Why?
|
| Overweight | 1 | 2020 | 558 | 0.120 |
Why?
|
| Panax | 1 | 2014 | 2 | 0.120 |
Why?
|
| Peripheral Arterial Disease | 1 | 2021 | 475 | 0.110 |
Why?
|
| Adipogenesis | 1 | 2014 | 55 | 0.110 |
Why?
|
| Mitochondria, Muscle | 1 | 2015 | 116 | 0.110 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2015 | 197 | 0.110 |
Why?
|
| Kidney | 1 | 2021 | 1468 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 815 | 0.100 |
Why?
|
| Nanocapsules | 1 | 2013 | 14 | 0.100 |
Why?
|
| Obesity | 3 | 2015 | 2992 | 0.100 |
Why?
|
| Middle Aged | 3 | 2023 | 33479 | 0.100 |
Why?
|
| Hypertension | 1 | 2021 | 1295 | 0.090 |
Why?
|
| Prospective Studies | 1 | 2022 | 7604 | 0.080 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1724 | 0.060 |
Why?
|
| Dinoprost | 1 | 2023 | 44 | 0.050 |
Why?
|
| Blood Flow Velocity | 1 | 2023 | 413 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 410 | 0.040 |
Why?
|
| Antioxidants | 1 | 2023 | 584 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 1023 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2023 | 561 | 0.040 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 383 | 0.040 |
Why?
|
| Adult | 1 | 2022 | 37929 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 2486 | 0.040 |
Why?
|
| Time Factors | 2 | 2021 | 6828 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 746 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2023 | 1317 | 0.030 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Mitochondrial Size | 1 | 2015 | 4 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2015 | 42 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2015 | 30 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 1477 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2014 | 36 | 0.030 |
Why?
|
| Hydrostatic Pressure | 1 | 2014 | 31 | 0.030 |
Why?
|
| Adipocytes, White | 1 | 2014 | 19 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 2804 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2015 | 200 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 810 | 0.030 |
Why?
|
| Emulsions | 1 | 2013 | 53 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4030 | 0.020 |
Why?
|
| Inflammation | 1 | 2023 | 2837 | 0.020 |
Why?
|
| Biomarkers | 1 | 2023 | 4149 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 3457 | 0.020 |
Why?
|
| Adiposity | 1 | 2015 | 518 | 0.020 |
Why?
|
| Weight Loss | 1 | 2015 | 787 | 0.020 |
Why?
|
| Animals | 3 | 2015 | 36940 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2015 | 1719 | 0.020 |
Why?
|
| United States | 1 | 2024 | 14841 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4295 | 0.010 |
Why?
|
| Rats | 1 | 2013 | 5647 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 5079 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 17787 | 0.010 |
Why?
|